Is Psilocybin Legal in Colorado? Decriminalization vs Licensed Access

It depends on what you mean by “legal.” In Colorado, personal use and possession of psilocybin mushrooms is decriminalized for adults 21+ under the Natural Medicine Health Act (Proposition 122, 2022). Colorado also operates a licensed healing-center model where adults can access facilitated psilocybin sessions through regulated providers (licensing began in 2024–2025).

However, at the U.S. federal level psilocybin remains a Schedule I controlled substance under the Controlled Substances Act (CSA), and there is no U.S. Food and Drug Administration (FDA)-approved psilocybin medicine. Retail sale and distribution are not permitted under Colorado’s program. This article is general information, not legal advice.

Colorado’s current status: decriminalized possession + regulated services

Colorado’s framework has two distinct parts that are often conflated:

• Decriminalization (state-level): For adults 21 and older, Colorado has decriminalized personal use, personal possession, and gifting of psilocybin and psilocin. Colorado’s decriminalization also covers N,N-DMT (dimethyltryptamine), ibogaine, and mescaline (non-peyote).
• Regulated therapeutic access (state-level): Proposition 122 also created a pathway for licensed healing centers to offer facilitated psilocybin sessions in a supervised setting.

At the same time, Colorado did not create a “dispensary” or adult-use retail system for psilocybin. In plain English: Colorado tolerates certain personal behaviors (decriminalization) and separately licenses supervised services (healing centers), but it does not authorize general commercial sales.

Federal law still governs: psilocybin is Schedule I and not FDA-approved

Even if an activity is decriminalized under state law, federal law can still apply. Under the U.S. Controlled Substances Act (CSA), psilocybin is Schedule I. Schedule I is the most restrictive category and triggers significant federal controls and penalties around manufacture, distribution, and possession.

Psilocybin is also not FDA-approved as a prescription medicine in the United States. That matters for how health systems, insurers, and prescribers can interact with it. Colorado’s healing-center model is not the same thing as an FDA-approved drug plus a standard medical prescription pathway.

Research and development are active. Two frequently cited late-stage programs are Compass Pathways’ COMP360 (a Phase 3 program reading out through 2025–2026) and Usona’s psilocybin program (IPR001) (Phase 3 ongoing). These clinical programs do not change today’s federal scheduling, but they help explain why states are experimenting with regulated access while federal approval remains pending. For a broader orientation, see our primer: /psychedelic-research-landscape.

What Proposition 122 actually created (and what it didn’t)

Proposition 122 (Natural Medicine Health Act, 2022) is the legal foundation for Colorado’s current approach. In practice, it does three things that matter to most readers:

• Reduces criminal exposure under state law for adults 21+ who personally possess and use psilocybin mushrooms (and certain other natural medicines) and who “gift” them in non-commercial contexts.
• Builds a state-regulated services system in which approved operators can provide psilocybin experiences in a supervised setting.
• Sets up governance for expansion by establishing review mechanisms for additional substances in the regulated program.

What Proposition 122 did not do is equally important for “is it legal?” searches:

• No retail sales: There is no licensed retail category for psilocybin “products” comparable to cannabis dispensaries, and retail distribution is not permitted.
• No blanket legalization: Decriminalization is not the same as making a substance fully legal across commercial supply chains.
• No change to federal status: Colorado law cannot reschedule psilocybin under federal law.

Colorado’s program is sometimes compared to Oregon’s state services model (Measure 109, 2023). Both are state-level therapeutic frameworks, not federal prescription systems. We track these concepts in our general legal hub: /law.

Common questions: gifting, edibles, other psychedelics, and peyote

Is “gifting” psilocybin legal in Colorado?

Under Proposition 122, gifting is part of what Colorado has decriminalized for adults 21+, meaning it is not a criminal offense under state law when done in the permitted context. Decriminalized does not mean “regulated commerce,” and it should not be read as permission for retail-style distribution.

Are psilocybin gummies or edibles legal to buy in Colorado?

Colorado’s Proposition 122 framework does not create a separately licensed retail product category for psilocybin edibles (including gummies). The state’s regulated access model is focused on psilocybin in a facilitator-supervised healing-center setting, not consumer retail.

Which psychedelics are included—and which aren’t?

Colorado’s decriminalization covers psilocybin/psilocin, DMT, ibogaine, and mescaline (non-peyote) for adults 21+ (personal use, possession, and gifting). However:

• MDMA (3,4-methylenedioxymethamphetamine) and LSD (lysergic acid diethylamide) are not included in Colorado’s decriminalization. They remain Schedule I under state law.
• Peyote is explicitly excluded from Colorado’s decriminalization statute in deference to NAC (Native American Church) concerns.

Separately, Colorado’s therapeutic program is designed to evolve. Under the current structure, DMT, mescaline, and ibogaine are scheduled for a 2026 advisory-board review for potential inclusion in the regulated healing-center program. That review is about therapeutic-program inclusion, not about changing federal scheduling.

Who regulates healing centers and facilitators?

Colorado’s supervised services are administered through state licensing. Healing centers began licensing in 2024–2025, and the Division of Professions and Occupations supervises facilitators (the professionals who oversee sessions in the licensed setting). The key point for readers: the state is regulating service provision, not authorizing open retail markets.

What to do next: verify claims, track rules, and avoid category errors

People get into trouble—legally and practically—by mixing up three categories: (1) decriminalized personal conduct, (2) state-licensed supervised services, and (3) federal Schedule I controls. If you are a researcher, journalist, or investor, the safest workflow is to validate which category a claim falls into before repeating it.

• If you’re reporting or doing diligence: Start with our orientation pages: /start and /briefing.
• If you need context on clinical development vs. state programs: See /psychedelic-research-landscape.
• If you’re comparing jurisdictions or tracking policy structures: Use /guides and our legal overview at /law.

Finally, remember the core answer: Colorado has decriminalized adult personal possession and use of psilocybin mushrooms and offers licensed, facilitated sessions at healing centers, but retail sales are not permitted, and federal Schedule I status still applies.